International Severe Asthma Registry : Mission Statement

The ISAR Study Group

International Severe Asthma Registry : Mission Statement

dc.contributor.author	The ISAR Study Group
dc.contributor.institution	University of Aberdeen.Institute of Applied Health Sciences	en
dc.contributor.institution	University of Aberdeen.Other Applied Health Sciences	en
dc.date.accessioned	2020-06-02T09:40:00Z
dc.date.available	2020-06-02T09:40:00Z
dc.date.issued	2020-04
dc.description	FUNDING/SUPPORT: ISAR is conducted by Optimum Patient Care Global (OPC) Limited, and cofunded by OPC Limited and AstraZeneca	en
dc.description.status	Peer reviewed	en
dc.format.extent	10
dc.format.extent	545951
dc.identifier	170263944
dc.identifier	afc88801-3a2a-4050-bfb4-8ed7dba2f9a4
dc.identifier	85082137760
dc.identifier	000523616200027
dc.identifier.citation	The ISAR Study Group 2020, 'International Severe Asthma Registry : Mission Statement', Chest, vol. 157, no. 4, pp. 805-814. https://doi.org/10.1016/j.chest.2019.10.051	en
dc.identifier.doi	10.1016/j.chest.2019.10.051
dc.identifier.iss	4	en
dc.identifier.issn	0012-3692
dc.identifier.uri	https://hdl.handle.net/2164/14423
dc.identifier.url	http://www.scopus.com/inward/record.url?scp=85082137760&partnerID=8YFLogxK	en
dc.identifier.vol	157	en
dc.language.iso	eng
dc.relation.ispartof	Chest	en
dc.subject	ISAR	en
dc.subject	severe asthma	en
dc.subject	DEFINITION	en
dc.subject	OMALIZUMAB	en
dc.subject	COSTS	en
dc.subject	ADULTS	en
dc.subject	PHENOTYPES	en
dc.subject	PREVALENCE	en
dc.subject	R Medicine (General)	en
dc.subject	Critical Care and Intensive Care Medicine	en
dc.subject	Cardiology and Cardiovascular Medicine	en
dc.subject	Pulmonary and Respiratory Medicine	en
dc.subject.lcc	R1	en
dc.title	International Severe Asthma Registry : Mission Statement	en
dc.type	Journal article	en

Files

Original bundle

Now showing 1 - 1 of 1

Name:: Price_et_al_Chest_InternationalSevereAsthma_VoR.pdf
Size:: 533.16 KB
Format:: Adobe Portable Document Format

Download

Collections

All research